GAO Ming, ZHOU Qing, WU Yi-long. Treatment Reform of Inoperable Stage Ⅲ Non-Small Cell Lung Cancer in the Immunotherapy Era[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 1-3. DOI: 10.12019/j.issn.1671-5144.2022.01.001
|
Citation:
|
GAO Ming, ZHOU Qing, WU Yi-long. Treatment Reform of Inoperable Stage Ⅲ Non-Small Cell Lung Cancer in the Immunotherapy Era[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 1-3. DOI: 10.12019/j.issn.1671-5144.2022.01.001
|
GAO Ming, ZHOU Qing, WU Yi-long. Treatment Reform of Inoperable Stage Ⅲ Non-Small Cell Lung Cancer in the Immunotherapy Era[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 1-3. DOI: 10.12019/j.issn.1671-5144.2022.01.001
|
Citation:
|
GAO Ming, ZHOU Qing, WU Yi-long. Treatment Reform of Inoperable Stage Ⅲ Non-Small Cell Lung Cancer in the Immunotherapy Era[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 1-3. DOI: 10.12019/j.issn.1671-5144.2022.01.001
|
DownLoad: